Document Detail

Are bio-absorbable stents the future of SFA treatment?
MedLine Citation:
PMID:  20081768     Owner:  NLM     Status:  MEDLINE    
Several limitations inherent to the implantation of a metallic device, such as the occurrence of in-stent re-stenosis, in an arterial lumen intuitively explain the interest for developing bio-absorbable stents. Two main types of bio-absorbable stents currently exist: polymer stents and metallic stents. To date, no studies with bio-absorbable stents have been conducted in the superficial femoral artery (SFA). Because of their strut thickness and lack of radial force, polymer stents are no good candidates for endovascular use. Absorbable metal stents (AMS) do have the potential to perform well for artery treatment, although current evidence from in-human coronary and infrapopliteal studies yield unsatisfactory results. Drastic technological improvements are mandatory before AMS can be considered for every day practice. Yet, it is our belief that further development of other metal and non-metal bio-absorbable stents, with or without drug-coating, may lead to the creation of the ultimate SFA stent.
P Peeters; K Keirse; J Verbist; K Deloose; M Bosiers
Related Documents :
11988608 - Carotid artery stenting protected with an emboli containment system.
17321348 - Fracture of a carotid stent: an unexpected complication.
20853358 - Long-term outcomes of intraoperative pulmonary artery stent placement for congenital he...
10092888 - The effects of crossing porcine renal artery ostia with various endovascular stents.
4045038 - The monostrut björk-shiley heart valve.
18554148 - The effects of pharmacological pai-1 inhibition on thrombus formation and neointima for...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Journal of cardiovascular surgery     Volume:  51     ISSN:  0021-9509     ISO Abbreviation:  J Cardiovasc Surg (Torino)     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-18     Completed Date:  2010-05-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0066127     Medline TA:  J Cardiovasc Surg (Torino)     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  121-4     Citation Subset:  IM    
Department of Cardiovascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty / adverse effects,  economics,  instrumentation*
Arterial Occlusive Diseases / economics,  physiopathology,  therapy*
Constriction, Pathologic
Femoral Artery* / physiopathology
Prosthesis Design
Treatment Outcome
Vascular Patency
Reg. No./Substance:
0/Metals; 0/Polymers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Are drug-eluting stents the future of SFA treatment?
Next Document:  Advances on drug-coated balloons.